Su Min-Wen, Chang Shen-Shin, Chen Chung-Hao, Huang Chien-Chi, Chang Shih-Wei, Tsai Yu-Chuan, Lam Chen-Fuh
Department of Anesthesiology, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan.
Department of Surgery, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan.
J Surg Res. 2014 Jun 1;189(1):135-42. doi: 10.1016/j.jss.2014.02.035. Epub 2014 Feb 24.
The development of warm-cold ischemia-reperfusion (IR) injury of the kidney grafts is inevitable during renal transplantation. However, there is currently no definite renoprotective strategy available in the protection of the graft tissue. In the present study, we compared the renal protection of preconditioning isoflurane with N-acetylcysteine (NAC) in a novel rat model of warm-cold renal IR injury.
Adult Sprague-Dawley rats were randomly assigned to receive inhaled isoflurane (1.5% for 2 h), NAC (1 g/kg, intra-arterial injection) or placebo before the induction of brief warm ischemia (10 min) followed by cold ischemia (45 min) periods. Plasma levels of creatinine and tissue inflammatory reaction in the kidney were analyzed 72 h after reperfusion.
Elevated plasma level of creatinine and urea indicated the development of acute renal injury secondary to IR injury. The creatinine levels were reduced in animals pretreated with inhaled isoflurane and NAC, and the level was more significantly decreased in the isoflurane-treated group. Preconditioning with volatile isoflurane also significantly suppressed the tissue myeloperoxidase activity and expression of the inducible nitric oxide synthase. Immunostaining confirmed that myeloperoxidase expression was most significantly attenuated in the glomerulus and peritubular capillaries of rats pre-exposed to isoflurane.
We present the first study demonstrating that the administration of volatile isoflurane before induction of experimental warm-cold renal IR injury provides preconditioning renoprotective effect, which is superior to the treatment with NAC. The beneficial renoprotective effect of isoflurane is most likely mediated by attenuation of proinflammatory reaction in the injured kidney.
在肾移植过程中,肾移植器官的温冷缺血再灌注(IR)损伤的发生是不可避免的。然而,目前在保护移植组织方面尚无明确的肾脏保护策略。在本研究中,我们在一种新型的温冷肾IR损伤大鼠模型中比较了异氟烷预处理与N - 乙酰半胱氨酸(NAC)的肾脏保护作用。
成年Sprague-Dawley大鼠被随机分配,在诱导短暂温缺血(10分钟)随后冷缺血(45分钟)之前,接受吸入异氟烷(1.5%,持续2小时)、NAC(1克/千克,动脉内注射)或安慰剂。再灌注72小时后分析血浆肌酐水平和肾脏组织炎症反应。
血浆肌酐和尿素水平升高表明继发于IR损伤的急性肾损伤的发生。吸入异氟烷和NAC预处理的动物肌酐水平降低,异氟烷治疗组的水平下降更显著。挥发性异氟烷预处理还显著抑制了组织髓过氧化物酶活性和诱导型一氧化氮合酶的表达。免疫染色证实,预先暴露于异氟烷的大鼠肾小球和肾小管周围毛细血管中的髓过氧化物酶表达最显著减弱。
我们首次表明,在实验性温冷肾IR损伤诱导前给予挥发性异氟烷可提供预处理肾脏保护作用,优于NAC治疗。异氟烷有益的肾脏保护作用很可能是通过减轻受损肾脏中的促炎反应介导的。